⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Phase II Study of the FIL on Elderly Frail Patients With DLBCL

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Phase II Study of the FIL on Elderly Frail Patients With DLBCL

Official Title: A Combination of Lenalidomide and Rituximab as Front Line Therapy for the Treatment of Elderly Frail Patients Evaluated in CGA With Diffuse Large B-cells Non-Hodgkin Lymphoma. A Phase II Study of the Fondazione Italiana Linfomi (FIL)

Study ID: NCT02955823

Study Description

Brief Summary: A phase II study to evaluate the combination of Lenalidomide and Rituximab as front line therapy for the treatment of elderly frail patients evaluated in CGA with Diffuse Large B-cells non-Hodgkin Lymphoma.

Detailed Description: This is a prospective, multicenter, single arm, phase II trial in elderly patients (≥ 70 years) affected by DLBCL defined as frail according to CGA and previously untreated. The primary endpoint is to evaluate the efficacy of the R2 (Revlimid+Rituximab) combination in first line DLBCL patients not candidate for the standard R-CHOP (or R-CHOP like) treatments due to the frail status.

Eligibility

Minimum Age: 70 Years

Eligible Ages: OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia, Meldola, Forlì-Cesena, Italy

A.O. C. Panico - U.O.C Ematologia e Trapianto, Tricase, Lecce, Italy

Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS - Ematologia, Reggio nell'Emilia, Reggio Emilia, Italy

Ospedale Dell'Angelo - U.O. Ematologia, Mestre, Venezia, Italy

Clinica di Ematologia A.O.Universitaria Ospedali Riuniti, Ancona, Ancona, , Italy

A.O. Spedali Civili di Brescia - Ematologia, Brescia, , Italy

IRCCS AOU S. Martino - IST - Clinica Ematologica, Genova, , Italy

Azienda Ospedali Riuniti Papardo-Piemonte - S.C. Ematologia, Messina, , Italy

ASST Grande Ospedale Metropolitano Niguarda, Milano, , Italy

Azienda Ospedaliero - Universitaria Policlinico di Modena - Dipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica, Modena, , Italy

I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1, Padova, , Italy

AOU di Parma - U.O. Complessa di Ematologia, Parma, , Italy

Ospedale Guglielmo da Saliceto - U.O.Ematologia, Piacenza, , Italy

Ospedale delle Croci - Ematologia, Ravenna, , Italy

Ospedale degli Infermi di Rimini - U.O. di Ematologia, Rimini, , Italy

Policlinico Universitario Campus Bio-Medico - Area Ematologia Trapianto Cellule Staminali Medicina Trasfusionale e Terapia cellulare, Roma, , Italy

Univ. Perugia Sede Terni - Oncoematologia, Terni, , Italy

Ospedale ULSS 6 di Vicenza - Ematologia, Vicenza, , Italy

Contact Details

Name: Guido Gini, MD

Affiliation: Clinica di Ematologia A.O.Universitaria Ospedali Riuniti, Ancona

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: